OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset
Lawrence F. Eichenfield, April W. Armstrong, Emma Guttman‐Yassky, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 6, pp. 1337-1350
Open Access | Times Cited: 6
Lawrence F. Eichenfield, April W. Armstrong, Emma Guttman‐Yassky, et al.
Dermatology and Therapy (2022) Vol. 12, Iss. 6, pp. 1337-1350
Open Access | Times Cited: 6
Showing 6 citing articles:
The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
Georgia Pappa, Dimitrios Sgouros, Konstantinos Theodoropoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5633-5633
Open Access | Times Cited: 19
Georgia Pappa, Dimitrios Sgouros, Konstantinos Theodoropoulos, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 19, pp. 5633-5633
Open Access | Times Cited: 19
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study
Alexa B. Kimball, Dimittri Delevry, Min Yang, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 9, pp. 2107-2120
Open Access | Times Cited: 10
Alexa B. Kimball, Dimittri Delevry, Min Yang, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 9, pp. 2107-2120
Open Access | Times Cited: 10
Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
Current and emerging drugs for the treatment of pruritus: an update of the literature
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
Rami H. Mahmoud, Sarah G Brooks, Gil Yosipovitch
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 655-672
Closed Access | Times Cited: 2
A systematic review of sex and gender differences in treatment outcome of inflammatory skin diseases: Is it time for new guidelines?
Sarah Preis, Stefanie Ziehfreund, Tilo Biedermann, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
Sarah Preis, Stefanie Ziehfreund, Tilo Biedermann, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
Big data- and machine learning-based analysis of a global pharmacovigilance database enables the discovery of sex-specific differences in the safety profile of dual IL4/IL13 blockade
Κassem Sharif, Mahmud Omar, Adi Lahat, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Κassem Sharif, Mahmud Omar, Adi Lahat, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
